HYFT

MindWalk Holdings Corp.
NASDAQHEALTHCAREBIOTECHNOLOGY

Key Statistics

Market Cap
$50.43M
P/E Ratio
—
EPS
$-0.26
Beta
0.78
52W High
$2.99
52W Low
$0.98
50-Day MA
$1.31
200-Day MA
$1.38
Dividend Yield
—
Profit Margin
-105.20%
Forward P/E
—
PEG Ratio
—

About MindWalk Holdings Corp.

MindWalk Holdings Corp. The company is headquartered in Austin, Texas.

Official WebsiteUSAFY End: April

Fundamentals

Revenue (TTM)$16.23M
Gross Profit (TTM)$9.87M
EBITDA$-16.10M
Operating Margin-159.90%
Return on Equity-123.70%
Return on Assets-36.40%
Revenue/Share (TTM)$0.35
Book Value$0.10
Price-to-Book9.74
Price-to-Sales (TTM)3.11
EV/Revenue3.882
EV/EBITDA-4.68
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)21.30%
Shares Outstanding$47.57M
Float$42.74M
% Insiders9.21%
% Institutions9.21%

Historical Volatility

HV 10-Day
58.75%
HV 20-Day
63.78%
HV 30-Day
69.68%
HV 60-Day
75.91%
HV Rank
8.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($4.33 target)
3
Buy

Latest News

MindWalk Holdings Corp. Announces Leadership Update

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that Thomas Lynch, PhD, has departed the company and ceased to serve as Chief Business Officer, effective October 16, 2026. "We thank Thomas for his contributions to MindWalk and wish him well," said Jennifer Bath, PhD, Chief Executive Officer and President of MindWalk. "Our commercial priorities do not change. We have moved from building the technology to deploying it,.

Business Wire10/22/2026Neutral
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

BOSTON--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (NASDAQ: HYFT) (“MindWalk” or the “Company”), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company's pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Orum Ther.

Business Wire10/14/2026Neutral
MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today outlined why the ontology layer now being built across enterprise AI does not reach biological function, and why life sciences requires a biological context layer of its own. ReefIQ™, MindWalk's biological context layer for life sciences, supplies what a horizontal ontology cannot: a governed, model-agnostic representation of what biology does, available from the first day of a de.

Business Wire10/6/2026Neutral
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with engineering partners AMD and Vultr on Vultr Kubernetes Engine and Vultr Cloud GPU powered by AMD Instinct™ MI325X GPUs and delivered through AMD Inference Microservices (AIM). It also served as an independent validation of AIM for OpenFold3 in a production life-sciences.

Business Wire9/21/2026Neutral
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (Cayman) for a senior unsecured revolving credit facility of up to US$30 million. The facility is intended to support MindWalk's biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on amounts drawn, an.

Business Wire9/14/2026Neutral
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD's Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD's channels. The demonstration is the first.

Business Wire7/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HYFT and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026